Radio-frequency-ablation for lung cancer under general anesthesia

Radio-frequency-ablation for lung cancer under general anesthesia - Radio-frequency-ablation for lung cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000050454

Enrollment

500

Registered

2023-04-01

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary lung cancer and metastatic lung cancer

Interventions

For patients with primary or metastatic lung cancer less than 3 cm, the followings are explained: 1. Standard treatment is surgery if resectable, 2. As non-surgical treatment, radiation therapy is the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Stage I primary lung cancer less than 3 cm. 2. Metastatic lung cancer less than 3 cm. 3. Patient requests RFA.

Exclusion criteria

Exclusion criteria: Sever pulmonary dysfunction

Design outcomes

Primary

Measure	Time frame
safety and efficacy	—

Secondary

Measure	Time frame
5 years recurrence-free survival	—

Countries

Japan

Contacts

Public ContactHiroaki Nomori

Kashiwa Kousei General Hospital Department of thoracic surgery

hnomori@qk9.so-net.ne.jp0471451111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026